220 related articles for article (PubMed ID: 19555871)
1. Renin angiotensin system inhibition in the older person: a review.
Mohamed MA; Weir MR
Clin Geriatr Med; 2009 May; 25(2):245-57. PubMed ID: 19555871
[TBL] [Abstract][Full Text] [Related]
2. Effects of renin-angiotensin system inhibition on end-organ protection: can we do better?
Weir MR
Clin Ther; 2007 Sep; 29(9):1803-24. PubMed ID: 18035185
[TBL] [Abstract][Full Text] [Related]
3. Recent changes in the landscape of combination RAS blockade.
Epstein BJ; Smith SM; Choksi R
Expert Rev Cardiovasc Ther; 2009 Nov; 7(11):1373-84. PubMed ID: 19900020
[TBL] [Abstract][Full Text] [Related]
4. Inhibiting the renin-angiotensin system: why and in which patients.
Berra K; Miller NH
J Am Acad Nurse Pract; 2009 Jan; 21(1):66-75. PubMed ID: 19125897
[TBL] [Abstract][Full Text] [Related]
5. Renin inhibition--benefit beyond hypertension control.
Kher V
J Assoc Physicians India; 2009 Jul; 57():518-20, 525. PubMed ID: 20329413
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of renin: an updated review of the development of renin inhibitors.
Li YC
Curr Opin Investig Drugs; 2007 Sep; 8(9):750-7. PubMed ID: 17729187
[TBL] [Abstract][Full Text] [Related]
7. [The future of renin inhibition].
Uresin AY; Baran E
Turk Kardiyol Dern Ars; 2009 Oct; 37 Suppl 7():32-8. PubMed ID: 20019475
[TBL] [Abstract][Full Text] [Related]
8. Beyond blood pressure: evidence for cardiovascular, cerebrovascular, and renal protective effects of renin-angiotensin system blockers.
Verdecchia P; Gentile G; Angeli F; Reboldi G
Ther Adv Cardiovasc Dis; 2012 Apr; 6(2):81-91. PubMed ID: 22528743
[TBL] [Abstract][Full Text] [Related]
9. Hypertension mega-trials with cardiovascular end points: effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers.
Kjeldsen SE; Julius S
Am Heart J; 2004 Nov; 148(5):747-54. PubMed ID: 15523303
[TBL] [Abstract][Full Text] [Related]
10. The renoprotective effects of RAS inhibition: focus on prevention and treatment of chronic kidney disease.
Weir MR
Postgrad Med; 2009 Jan; 121(1):96-103. PubMed ID: 19179817
[TBL] [Abstract][Full Text] [Related]
11. [Pathophysiological and clinical implications of AT(1) and AT(2) angiotensin II receptors in essential hypertension].
Burnier M
Drugs; 2002; 62 Spec No 1():21-9. PubMed ID: 12036386
[TBL] [Abstract][Full Text] [Related]
12. Progression of renal disease: renoprotective specificity of renin-angiotensin system blockade.
Griffin KA; Bidani AK
Clin J Am Soc Nephrol; 2006 Sep; 1(5):1054-65. PubMed ID: 17699327
[TBL] [Abstract][Full Text] [Related]
13. Clinical trials in nephrology: success or failure.
Garcia-Donaire JA; Segura J; Ruilope LM
Curr Opin Nephrol Hypertens; 2007 Mar; 16(2):59-63. PubMed ID: 17293678
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic possibilities for the inhibition of the renin-angiotensin-aldosterone system].
Abrahám G; Légrády P
Orv Hetil; 2003 May; 144(18 Suppl 1):892-5. PubMed ID: 12785232
[TBL] [Abstract][Full Text] [Related]
15. Defining the role of renin/angiotensin-targeted antihypertensive therapy in decreasing cardiovascular risk: evidence, guideline evolution, and questions to be resolved.
Probstfield J
J Fam Pract; 2009 Jun; 58(6 Suppl):S1-8. PubMed ID: 19508849
[No Abstract] [Full Text] [Related]
16. Common genetic variations of the renin-angiotensin-aldosterone system and response to acute angiotensin I-converting enzyme inhibition in essential hypertension.
Hannila-Handelberg T; Kontula KK; Paukku K; Lehtonen JY; Virtamo J; Tikkanen I; Hiltunen TP
J Hypertens; 2010 Apr; 28(4):771-9. PubMed ID: 20027122
[TBL] [Abstract][Full Text] [Related]
17. Does interference with the renin-angiotensin system protect against diabetes? Evidence and mechanisms.
van der Zijl NJ; Moors CC; Goossens GH; Blaak EE; Diamant M
Diabetes Obes Metab; 2012 Jul; 14(7):586-95. PubMed ID: 22226145
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of the renin angiotensin aldosterone system: focus on aliskiren.
Rao MS
J Assoc Physicians India; 2010 Feb; 58():102-8. PubMed ID: 20653151
[TBL] [Abstract][Full Text] [Related]
19. [Historical perspective of renin-angiotensin system blocking in the treatment of arterial hypertension].
Coca A; Redón J
Med Clin (Barc); 1996 Mar; 106(12):457-9. PubMed ID: 8656731
[No Abstract] [Full Text] [Related]
20. RAS inhibition in hypertension.
Ibrahim MM
J Hum Hypertens; 2006 Feb; 20(2):101-8. PubMed ID: 16397519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]